CMPS's Quality Score fell 1 point on Tue, Nov 10, to -4. Its average price of the last 200 days turned down.
Follow CMPS's trial news. Pro members can get an alert when COMPASS Pathways files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 9% over the five sessions to Nov 9 while the S&P 500 rose 0.1%.
| Holding it back | 45.5% more shares than a year ago |
| Latest filing | 8-K, Nov 3 |
Compass files antitrust suit against CRMLS over listing rules
CMPS closed −7.5% that day on 1.9x normal volume.
Wed Nov 11: Stifel Healthcare Conference 2026Investor conference · date confirmed.
After its last 4 reports it closed +8.0% on average, higher 3 of 4 times.
The company says its cash lasts into 2028 (8-K, Nov 3).
No shelf registration or at-the-market program on file in the last three years.
No open-market buys or sales by its officers or directors in their filings of the last year.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
Poorfor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
CMPS is #76 of 90 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 76 |
Expected to report Tue Mar 23, before the open (in 133 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The decrease in net loss was primarily driven by non-cash fair value adjustments related to our warrants.”
CMPS's results filing gives no sales by line in a table we read. Its annual report gives the year's, in About.
No outlook figures read from this release.
“The increase was primarily due to increased costs to support our commercial preparedness activities in advance of potential FDA approval and commercialization of COMP360 for TRD, including investments in commercial infrastructure, market access and reimbursement capabilities, supply chain readiness and other launch preparation activities.”
From its results filing (SEC filing · Nov 3)
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 3, 2026 | +7.0% | +2.1% | +9.2% |
| Aug 5, 2026 | -1.7% | +15.1% | +13.4% |
| May 13, 2026 | +5.1% | +17.0% | +7.5% |
| Mar 24, 2026 | -0.8% | -2.3% | -1.9% |
RSI 39.6, MACD below signal, below both averages. Not scored.
Officers and directors with a Form 4 in the last 12 months.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
CMPS scores -4 today, which Breakaway calls Poor. It is #76 of 90 in Pharma by Quality Score, with 3 of 14 chart checks firing. Up 9% over the five sessions to Nov 9 while the S&P 500 rose 0.1%. Shares: 45.5% more than a year ago (to Sep 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
CMPS scores -4 today, which Breakaway calls Poor (below zero). That is #76 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CMPS's -4.
Expected to report Tue Mar 23, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. CMPS closed higher after 3 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.